{"id":753,"date":"2017-02-14T08:50:20","date_gmt":"2017-02-14T07:50:20","guid":{"rendered":"http:\/\/intervacc.se\/en\/?page_id=753"},"modified":"2017-02-18T22:23:30","modified_gmt":"2017-02-18T21:23:30","slug":"partners-eng","status":"publish","type":"page","link":"https:\/\/intervacc.se\/en\/about-us\/partners-eng\/","title":{"rendered":"Partners"},"content":{"rendered":"\n<table id=\"tablepress-14\" class=\"tablepress tablepress-id-14\">\n<tbody class=\"row-hover\">\n<tr class=\"row-1\">\n\t<td class=\"column-1\"><img src=\"\/wp-content\/uploads\/2017\/02\/SLU.gif\" alt=\"\" width=\"90\" height=\"89\" class=\"alignnone size-full wp-image-431\" \/><\/td><td class=\"column-2\"><A href=\"http:\/\/www.slu.se\/\">The Swedish University of Agricultural Sciences <\/A> (SLU), Uppsala.<br \/>\n<br \/>\nSLU, the Swedish University of Agricultural Sciences, is one of our partners for the development of a new generation of animal health vaccines using recombinant proteins. SLU is a world-class international university with research, education and environmental assessment within the sciences for sustainable life. <\/td>\n<\/tr>\n<tr class=\"row-2\">\n\t<td class=\"column-1\"><img src=\"\/wp-content\/uploads\/2017\/02\/ki.gif\" alt=\"\" width=\"220\" height=\"90\" class=\"alignnone size-full wp-image-426\" \/><\/td><td class=\"column-2\"><a href=\"http:\/\/www.ki.se\/\" target=\"_blank\" rel=\"noopener\">Karolinska Institute<\/a>, KI, Stockholm.<br \/>\n<br \/>\nKarolinska Institutet, KI is one of our partners for the development of a new generation of animal health vaccines using recombinant proteins. KI is one of the world\u2019s foremost medical universities including both research and education with a vision is to advance knowledge about life and strive towards better health for all.<\/td>\n<\/tr>\n<tr class=\"row-3\">\n\t<td class=\"column-1\"><img src=\"\/wp-content\/uploads\/2017\/02\/moredun-scientific.png\" alt=\"Moredun Scientific\" width=\"120\" height=\"120\" class=\"alignnone size-full\" \/><\/td><td class=\"column-2\"><a href=\"http:\/\/www.moredun.org.uk\/moredun-scientific-homepage\" target=\"_blank\" rel=\"noopener\">Moredun Scientific<\/a>, Edinburgh, Skottland.<br \/>\n<br \/>\nOur cooperating partner in the Eurostars-2 funded project for further development of a vaccine against infection of piglets caused by Streptococcus suis. Moredun Scientific is a contract research organisation specialising in animal health and biosafety testing of biopharmaceuticals.<\/td>\n<\/tr>\n<tr class=\"row-4\">\n\t<td class=\"column-1\"><img src=\"\/wp-content\/uploads\/2017\/10\/logo3Pbio.png\" alt=\"\" width=\"126\" height=\"144\" class=\"alignnone size-full \" \/><\/td><td class=\"column-2\"><a href=\"http:\/\/www.3pbio.com\/\" target=\"_blank\" rel=\"noopener\">3P Biopharmaceuticals<\/a>, Pamplona, Spain<br \/>\n<br \/>\n3P Biopharmaceuticals is our partner for contract manufacturing of Strangvac<sup>\u00ae<\/sup>, Intervacc\u00b4s recombinant vaccine against strangles. The collaboration between the Companies covers transfer of the manufacturing technology, production of validation batches and long term future commercial manufacturing.<\/td>\n<\/tr>\n<tr class=\"row-5\">\n\t<td class=\"column-1\"><img src=\"\/wp-content\/uploads\/2020\/05\/logo.png\" alt=\"LIOF-Pharma (previosly Praxis Pharmaceutical)\" width=\"220\" height=\"70\" class=\"alignnone size-full \" \/><\/td><td class=\"column-2\"><a href=\"http:\/\/www.liofpharma.com\/\" target=\"_blank\" rel=\"noopener\">LIOF-Pharma (previosly Praxis Pharmaceutical)<\/a>, Spain<br \/>\n<br \/>\nLIOF-Pharma in Spain provides final formulation, filling of vials and packaging of finished product.<\/td>\n<\/tr>\n<tr class=\"row-6\">\n\t<td class=\"column-1\"><img src=\"\/wp-content\/uploads\/2017\/02\/novavax-logo.png\" alt=\"\" width=\"209\" height=\"50\" class=\"alignnone size-full wp-image-423\" \/><br \/>\n<\/td><td class=\"column-2\"><a href=\"http:\/\/www.novavax.com\/\" target=\"_blank\" rel=\"noopener\">Novavax AB<\/a>, Uppsala<br \/>\n<br \/>\nNovavax have developed a patented technology that enhances the effect of vaccines (adjuvants). The technique is based on different immune-stimulating components, saponins, which are extracted from the tree Quillaja saponaria. Following purification the immune-stimulating components produce different complexes named iscomes. Iscomes are included in several authorised vaccines amongst one of which is a vaccine against horse influensa. Intervacc has an agreement with Novavax to use the iscome technology in its strangles vaccine.<\/td>\n<\/tr>\n<tr class=\"row-7\">\n\t<td class=\"column-1\"><img src=\"\/wp-content\/uploads\/2017\/02\/awapatent.png\" alt=\"AWA Patent\" width=\"240\" height=\"30\" class=\"alignnone size-full\" \/><\/td><td class=\"column-2\"><a href=\"http:\/\/www.awapatent.com\/sv\" target=\"_blank\" rel=\"noopener\">AWA Patent<\/a>, Stockholm <br \/>\n<br \/>\nPatent agency<\/td>\n<\/tr>\n<tr class=\"row-8\">\n\t<td class=\"column-1\"><img src=\"\/wp-content\/uploads\/2019\/08\/cirio-logo-180x49.png\" alt=\"Cirio Law Firm\" width=\"150\" height=\"41\" class=\"alignnone size-full\" \/><\/td><td class=\"column-2\"><a href=\"http:\/\/www.cirio.se\" target=\"_blank\" rel=\"noopener\">Cirio Law Firm<\/a>, Stockholm<br \/>\n<br \/>\nLegal issues<\/td>\n<\/tr>\n<tr class=\"row-9\">\n\t<td class=\"column-1\"><img src=\"\/wp-content\/uploads\/2020\/01\/PwC_Logo_small-120x91.png\" alt=\"PwC\" width=\"120\" height=\"91\" class=\"alignnone size-full\" \/><\/td><td class=\"column-2\"><a href=\"http:\/\/www.pwc.se\" target=\"_blank\" rel=\"noopener\">PwC<\/a>, Sweden<br \/>\n<br \/>\nAudit and Financial advisory<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<!-- #tablepress-14 from cache -->\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>&nbsp;<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":746,"menu_order":6,"comment_status":"closed","ping_status":"closed","template":"page-full-width.php","meta":{"inline_featured_image":false},"_links":{"self":[{"href":"https:\/\/intervacc.se\/en\/wp-json\/wp\/v2\/pages\/753"}],"collection":[{"href":"https:\/\/intervacc.se\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/intervacc.se\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/intervacc.se\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/intervacc.se\/en\/wp-json\/wp\/v2\/comments?post=753"}],"version-history":[{"count":5,"href":"https:\/\/intervacc.se\/en\/wp-json\/wp\/v2\/pages\/753\/revisions"}],"predecessor-version":[{"id":1310,"href":"https:\/\/intervacc.se\/en\/wp-json\/wp\/v2\/pages\/753\/revisions\/1310"}],"up":[{"embeddable":true,"href":"https:\/\/intervacc.se\/en\/wp-json\/wp\/v2\/pages\/746"}],"wp:attachment":[{"href":"https:\/\/intervacc.se\/en\/wp-json\/wp\/v2\/media?parent=753"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}